Dialysis Market By Type (Hemodialysis, Peritoneal Dialysis), By Application (Equipment [Dialysis Machines, Water Treatment Systems, Others], Consumables [Dialyzers, Catheters, Access Products, Concentrates, Others], Services [Acute dialysis, Chronic dialysis]), By End User (In-center Dialysis, Home Dialysis), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The dialysis market accounted for USD 98.5 Billion in 2024 and is expected to reach USD 190.9 Billion by 2035, growing at a CAGR of around 6.2% between 2025 and 2035. The dialysis market involves the provision of medical treatments for patients with kidney failure. These treatments include either hemodialysis or peritoneal dialysis to replace the functions of the kidneys. It includes devices and equipment for the respective procedures, as well as consumables needed for treatment, such as dialyzers and dialysis solutions. The market is considered to be growing given the aging population and the increasing deaths associated with chronic kidney diseases.

Report Scope:

Market Dynamics

• The increasing rate of chronic kidney disease due to factors like diabetes and hypertension drives demand for dialysis treatments.

The rising incidence of chronic kidney disease (CKD) is driving the demand for dialysis treatments, significantly attributed to the increasing prevalence of conditions such as diabetes and hypertension. CKD is estimated to affect roughly 13% of the global adult population, according to the World Health Organization (WHO), with diabetes and hypertension indicated as the important risk factors. The Global Burden of Disease Study stated that, globally, hypertension affects billions of people and is one of the leading causes of kidney disease. The increasing burden of CKD presents an urgent need for effective dialysis solutions to both manage and treat CKD.

• High cost of dialysis, including equipment and ongoing care, can be prohibitive for many patients and healthcare systems.

The exorbitant expense of dialysis therapy continues to be a major constraint for dialysis market growth. Costs include the equipment needed for treatment (dialysis machines and related items) and the care and upkeep of patients receiving dialysis therapy. The expense of therapy can be prohibitive to many, especially without insurance coverage or available finances.

For healthcare systems, the cost of providing dialysis can strain budgets, potentially limiting access and availability of treatments. These financial challenges can hinder market growth by restricting the expansion of dialysis facilities and services. Addressing these cost barriers is crucial for improving accessibility and sustainability in the dialysis market.

• Development of advanced technologies, such as wearable dialysis devices and smart monitoring systems, opens new market possibilities.

The ongoing innovation in technology, including wearable dialysis machines and smart monitoring systems, opens numerous opportunities for the dialysis market. Wearable dialysis equips patients with the opportunity for more mobility and flexibility than traditional, stationary dialysis options. Patients can undergo treatment while maintaining an active lifestyle which substantially increases their quality of life and treatment adherence. Smart monitoring systems with real-time data analytics and remote monitoring also advance the management of patients by allowing a care team to respond quickly and provide tailored care.

All these advancements offer increased market opportunities in the wake of growing demand for simplified and efficient dialysis options. Innovations in both wearable dialysis machines and smart monitoring systems will enhance market opportunities in the dialysis market by creating better experiences for patients while inducing growth in the market. 

Industry Experts Opinion

"With the dearth of innovation in peritoneal dialysis over the past decades whereas kidney failure is on the rise worldwide, we need breakthroughs that fundamentally revolutionize dialysis. The next generation dialysis solution ought to not only be lifesaving but also restore productivity and dignity with convenience and ease for the millions of ESRD patients.

• Irene Guo, Co-CEO of Lion X Ventures

“India, being the diabetes capital of the world, has the highest number of prevalent kidney disease patients. There is a lack of proper infrastructure and access to specialized renal care clinics. To fund the expansion project, Nephrocare India plans to invest Rs 70 crore in ramping up the initial 22 centres by March 2026.”

“We have the vision to reach out to one million patients suffering from chronic kidney disease by setting up 300 such centers across the country in the next 10-15 years”

• Dr Pratim Sengupta, founder of Nephrocare India

“There continues to be increasing market demand for our hemodialysis portfolio of products. We are excited by the opportunity this (Nipro and Rockwell) partnership continues to offer Rockwell Medical and the patients who will be positively impacted by our hemodialysis concentrates worldwide."

• Mark Strobeck, Ph.D., President and CEO at Rockwell Medical

Segment Analysis

Based on the product type, hemodialysis is viewed as significantly more important than peritoneal dialysis. The hemodialysis market is significant because it is the most widely used method in the clinical setting, specifically in hospitals and dialysis centers. This method involves filtering blood through a machine outside the body and is often preferred for its protocols and infrastructure. The high prevalence of chronic kidney disease and the need for frequent, intensive treatment sessions further boost the demand for hemodialysis.

Based on the application, Consumables is the dominant section. Dialysis consumables encompass fundamental items such as dialyzers, catheters, and concentrates which are used consistently throughout the process of dialysis. These are essential for the proper functioning of dialysis and are consumed in large quantities. They are a significant part of the market due to frequent use and a relatively lower cost than equipment. The continued need for dialysis consumables in both the acute and chronic setting ensures their volumetric majority of the market.

Regional Analysis

The market for dialysis in North America is robust and developing with significant momentum, influenced by the increasing prevalence of chronic kidney disease as well as the increasing rates of diabetes. Leading-edge features, technologies, and therapies are supported by sufficient investment in research and development. Furthermore, key providers in the North American market, such as Fresenius Medical Care and DaVita Inc. lead North America with varying types of products and services.

North America also benefits from advanced healthcare infrastructure, with extensive dialysis centers and facilities that offer both in-center and home therapy options. The healthcare infrastructure combined with leading-edge technologies provides a comprehensive foundation for the expansion of the dialysis market in the county.

Competitive Landscape

The competitive landscape in the dialysis market is dynamic, with key players engaging in innovation and consolidation. The top 3 companies in the dialysis market, Fresenius Medical Care, Baxter International and DaVita Inc., offer a choice of products and services to meet different patient needs. Fresenius Medical Care is well known for advanced dialysis machines including the 5008S and the 4008S. Baxter provides a complete line of best-in-class peritoneal dialysis devices plus other complementary products.

Another top competitor, DaVita, offers in-center hemodialysis as well as home dialysis services. Moreover, there are emerging companies, like Nipro Corporation and B. Braun, are implementing innovative technologies and developing new product portfolios. The dialysis market is also seeing growth in areas like personalized medicine and remote monitoring that are facilitated by medical technology innovation and increased patient demands for more flexible and convenient treatment options.

Dialysis Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In March 2024, Rockwell Medical signed a multi-million-dollar distribution agreement with Nipro Medical to globally distribute its hemodialysis concentrates and mixers.
• In Dec 2023, Nephrocare announced its plan to establish 22 new kidney care centers in India by March 2026. This expansion aims to enhance access to specialized kidney care and support for patients across the country.
• In Sept 2023, AWAK Technologies raised over $20 million to advance its ultra-portable peritoneal dialysis system. This innovative device allows kidney disease patients to undergo dialysis both in the comfort of their homes and at mobility.

Report Coverage:

By Type

• Hemodialysis
• Peritoneal Dialysis

By Application

• Equipment

• Dialysis Machines
• Water Treatment Systems
• Others

• Consumables

• Dialyzers
• Catheters
• Access Products
• Concentrates
• Other

• Services
  • Acute dialysis
  • Chronic dialysis
• By End User
  • In-center Dialysis
  • Home Dialysis

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• AngioDynamics, Inc.
• Asahi Kasei Medical Co., Ltd.
• B. Braun SE
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Cantel Medical
• DaVita Inc.
• Dialife SA
• Fresenius Medical Care AG
• JMS Co., Ltd.
• Medtronic Plc
• Nikkiso Co., Ltd.
• Nipro Corporation
• Teleflex Incorporated
• Toray Industries Inc.

Frequently Asked Questions (FAQs)